Nattokinase is a dietary supplement containing nattokinase, an enzyme which has been attracting significant scientific interest since its discovery in a traditional Japanese food (natto) and the confirmation a few years later of its exceptional properties.
What is fibrinolysis?
Fibrinolysis is a normal, breakdown process in which clots of fibrin (a filamentous protein) are broken down by the enzyme plasmin. This reduces the amount of fibrin in the blood, and as a result, helps to protect the body against thrombosis, the process in which a blood clot forms in and obstructs a blood vessel.
Plasmin is an enzyme produced by the liver, initially in an inactive form, plasminogen. This binds to fibrin, and if a clot forms, the plasminogen becomes activated and cuts the fibrin in different places.
This normal reaction is facilitated by activators such as urokinase and Tissue Plasminogen Activator (t-PA) secreted by the vessel wall following a trauma. These activators work primarily by converting the plasminogen into plasmin (2).
What causes thrombosis?
Thrombosis is defined as the obstruction of a blood vessel by a clot. It can be venous (phlebitis, pulmonary embolism) or arterial (heart attack, stroke …).
Most of the time, thrombosis occurs after damage to a vessel wall following gradual hardening and loss of elasticity. This is called atherosclerosis.
Atherosclerosis is normally seen in those over 40 but there are certain groups of people at higher risk:
- smokers;
- those who are overweight;
- diabetics;
- those who do no daily exercise;
- those who suffer with bleeding disorders;
- those with a long history of poor dietary habits;
- those who’ve been subjected to daily stress for several years.
WARNINGS
Do not exceed the recommended daily dose. This product is a nutritional supplement and should not be used as a substitute for a varied and balanced diet or a healthy lifestyle.
STORAGE
Store in a cool, dry place away from direct sunlight, heat, and humidity.
Keep out of reach of children.
PREGNANCY AND MEDICAL CONDITIONS
If you are pregnant, breastfeeding, or have any medical conditions, consult your healthcare provider before using this product.
SUPPLEMENT INTERACTIONS
Consult your healthcare provider before use, especially if you are taking any medications or other supplements as there may be potential interactions.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Serving Size: 2 capsules
Servings per Container: 30 |
Amount per Serving |
Nattokinase (Fermented soybean extract) |
(2000 FU) 100 mg |
Other ingredient: acacia gum. |
Warning: Contains soya.
take 2 capsules a day, on an empty stomach.
for adults. Do not exceed the recommended daily dose. This product is a dietary supplement which should not be used to replace a varied, balanced diet or healthy lifestyle. Keep out of young children’s reach. Store away from light, head and humidity.
- Chen H, McGowan EM, Ren N, et al. Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases. Biomark Insights. 2018;13:1177271918785130. Published 2018 Jul 5. doi:10.1177/1177271918785130
- Susen, S., Zawadzki, C., Asseman, P., & Jude, B. (2006). Traitements fibrinolytiques. EMC - Hématologie, 1(1), 1–8. doi:10.1016/s1155-1984(03)000
- Nagata C, Wada K, Tamura T, et al. Dietary soy and natto intake and cardiovascular disease mortality in Japanese adults: the Takayama study. Am J Clin Nutr. 2017;105:426–431.
- Sumi H, Hamada H, Tsushima H, Mihara H, Muraki H. A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto; a typical and popular soybean food in the Japanese diet. 1987;43:1110–1111.
- Urano T, Ihara H, Umemura K, et al. The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis cleaves and inactivates plasminogen activator inhibitor type 1. J Biol Chem. 2001;276:24690–24696.
- Fujita M, Hong K, Ito Y, Fujii R, Kariya K, Nishimuro S. Thrombolytic effect of nattokinase on a chemically induced thrombosis model in rat. Biol Pharm Bull. 1995;18:1387–1391.
- Fu Y-S, Li Y-L, Zhang Y. Toxicological safety assessment on safety of nattokinase capsule. Prac Prev Med. 2012;19:1714–1716.